Charles River Laboratories International, Inc. ( CRL) - Key Metrics
CRL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $20.71 | -$0.03 | $3.71 | $3.07 |
| 2026Q1 | $20.34 | -$0.30 | $0.84 | -$0.30 |
| 2025Q4 | $20.20 | -$5.62 | $3 | $1.19 |
| 2025Q3 | $20.42 | $1.11 | $4.34 | $3.62 |
| 2025Q2 | $21 | $1.06 | $4.16 | $3.44 |
CRL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1797.92 |
| 2026Q1 | 0% | -132.63 |
| 2025Q4 | 0% | -9.06 |
| 2025Q3 | 0% | 33.46 |
| 2025Q2 | 0% | 35.38 |
CRL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.42% | 0% |
| 2026Q1 | -0.19% | 0% |
| 2025Q4 | 0.58% | 0% |
| 2025Q3 | 2.44% | 0% |
| 2025Q2 | 2.30% | 0% |
CRL
Price: $288.50
52 week price:
Payout Ratio Range:
Earnings Per Share: -4.82 USD
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 411300
Ebitda: 110.3 millionMarket Capitalization: 13.9 billion